(MENAFN- GlobeNewsWire - Nasdaq) Boost ROI via AI/cloud and quantum tools, SaaS, integrated data ecosystems, digital channels, value-based contracts, targeted promotion, partnerships and user training.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "Life Sciences IT Global Market Opportunities and Strategies to 2035" has been added to ResearchAndMarkets.com's offering.
The global life sciences IT market is positioned for sustained expansion as pharmaceutical, biotechnology and research organizations increase their investment in digital platforms, advanced analytics and data-driven workflows. Covering the historic period from 2020 to 2025 and providing forecasts through 2030 and 2035, the market analysis examines growth across major regions and economies.
The life sciences IT market reached approximately $29.14 billion in 2025, representing a compound annual growth rate (CAGR) of 12.1% since 2020. The market is projected to increase to $49.79 billion by 2030 at a CAGR of 11.3%. Growth is expected to continue at a CAGR of 10.6% from 2030, taking the global market value to approximately $82.24 billion by 2035.
Historic market growth was supported by rising pharmaceutical research and development spending, the expansion of precision medicine and genomics research, an increasing number of clinical trials and greater emphasis on drug safety monitoring. However, data privacy concerns and high implementation costs constrained adoption during the period.
Future growth in the life sciences IT market will be driven by rising healthcare expenditure, growing demand for real-world evidence and advanced data analytics, increasing government support for medical research and the rapidly expanding volume of biomedical data. Potential market barriers include difficulties integrating modern platforms with legacy IT infrastructure, stringent regulatory compliance requirements and the effects of trade disputes and tariffs.
Key life sciences IT market trends include the integration of quantum computing and advanced computational platforms into research environments. Organizations are also adopting artificial intelligence-driven commercialization and marketing automation platforms, cloud-based inspection systems, AI-enabled manufacturing analytics and integrated data and engagement platforms. These technologies are expected to strengthen research productivity, improve operational visibility and support more informed decision-making across life sciences organizations.
By type, the market is segmented into software and services. Services represented the largest segment in 2025, accounting for 60.9% of the global market, or approximately $17.74 billion. Software is forecast to be the fastest-growing type segment between 2025 and 2030, advancing at a CAGR of 12.7% as life sciences companies accelerate their adoption of scalable analytics, research and workflow platforms.
By solution, the life sciences IT market includes drug discovery informatics, clinical trial management, bioinformatics, laboratory information management and other solutions. Drug discovery informatics was the largest solution segment in 2025, generating approximately $8.67 billion and accounting for 29.8% of the market. Bioinformatics is expected to record the fastest growth through 2030, with a projected CAGR of 12.7%, supported by increasing genomics activity and biomedical data volumes.
By end user, the market serves pharmaceutical and biotechnology companies, contract research and development organizations and other users. Pharmaceutical and biotechnology companies held the largest share in 2025, accounting for 63.1% of the market, or approximately $18.39 billion. Contract research and development organizations are forecast to become the fastest-growing end-user segment, expanding at a CAGR of 13% between 2025 and 2030.
North America led the global life sciences IT market in 2025, accounting for 36.4% of total revenue, or approximately $10.61 billion. The region was followed by Asia-Pacific, Western Europe and other global markets. Asia-Pacific is forecast to be the fastest-growing region through 2030, with a CAGR of 13.2%, followed by Eastern Europe at 11.4%. Western Europe and North America are projected to grow at CAGRs of 11.2% and 10.3%, respectively.
Markets Covered:
By Type: Software; Service By Solution: Drug Discovery Informatics; Clinical Trial Management; Bioinformatics; Laboratory Information Management; Other Solutions By End User: Pharmaceutical and Biotechnology Companies; Contract Research and Development Organizations; Other End Users Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; life sciences IT indicators comparison.
Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment